nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A deliberate choice? Exploring factors related to informed decision-making about childhood vaccination among acceptors, refusers, and partial acceptors
|
Romijnders, Kim A.G.J. |
|
2019 |
37 |
37 |
p. 5637-5644 |
artikel |
2 |
Corrigendum to “A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains” [Vaccine 37 (2019) 2369–2376]
|
Ross, Ted M. |
|
2019 |
37 |
37 |
p. 5664 |
artikel |
3 |
Defining hard-to-reach populations for vaccination
|
Ozawa, Sachiko |
|
2019 |
37 |
37 |
p. 5525-5534 |
artikel |
4 |
Editorial Board/Aims and Scope
|
|
|
2019 |
37 |
37 |
p. IFC |
artikel |
5 |
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis
|
Keitel, W.A. |
|
2019 |
37 |
37 |
p. 5535-5543 |
artikel |
6 |
Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease
|
Hassan, Wisam Salim |
|
2019 |
37 |
37 |
p. 5596-5606 |
artikel |
7 |
Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis
|
Zhao, Fangfang |
|
2019 |
37 |
37 |
p. 5588-5595 |
artikel |
8 |
Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory
|
Paton, D.J. |
|
2019 |
37 |
37 |
p. 5515-5524 |
artikel |
9 |
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
|
Akhtar, Marjahan |
|
2019 |
37 |
37 |
p. 5645-5656 |
artikel |
10 |
Household costs of seeking BCG vaccination in rural Guinea-Bissau
|
Thysen, Sanne M. |
|
2019 |
37 |
37 |
p. 5505-5508 |
artikel |
11 |
HPV vaccine uptake in men who have sex with men in Scotland
|
Pollock, K.G. |
|
2019 |
37 |
37 |
p. 5513-5514 |
artikel |
12 |
Identifying inequalities in childhood immunisation uptake and timeliness in southeast Scotland, 2008–2018: A retrospective cohort study
|
Haider, Eram A. |
|
2019 |
37 |
37 |
p. 5614-5624 |
artikel |
13 |
Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3–6 years and 2–35 months of age- an open-label, randomized phase IIb clinical trial
|
Hung, Miao-Chiu |
|
2019 |
37 |
37 |
p. 5559-5566 |
artikel |
14 |
Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children
|
MacIntyre, C. Raina |
|
2019 |
37 |
37 |
p. 5630-5636 |
artikel |
15 |
Potential impact of a Moraxella catarrhalis vaccine in COPD
|
Perez, Antonia C. |
|
2019 |
37 |
37 |
p. 5551-5558 |
artikel |
16 |
Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana
|
Cooper, Laura V. |
|
2019 |
37 |
37 |
p. 5657-5663 |
artikel |
17 |
Stable dynamics of pneumococcal carriage over a decade in the pre-PCV era
|
Wagner, Bradley G. |
|
2019 |
37 |
37 |
p. 5625-5629 |
artikel |
18 |
Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme
|
Gebauer, Mandy |
|
2019 |
37 |
37 |
p. 5578-5587 |
artikel |
19 |
Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine
|
Guo, Angela |
|
2019 |
37 |
37 |
p. 5509-5512 |
artikel |
20 |
Therapeutic effect of DNA vaccine encoding the 60-kDa-heat shock protein from Paracoccidoides brasiliensis on experimental paracoccidioidomycosis in mice
|
Souza, Igor Emiliano L. |
|
2019 |
37 |
37 |
p. 5607-5613 |
artikel |
21 |
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
|
Asthagiri Arunkumar, Guha |
|
2019 |
37 |
37 |
p. 5567-5577 |
artikel |
22 |
Vaccine-preventable diseases, vaccines and Guillain-Barre’ syndrome
|
Principi, Nicola |
|
2019 |
37 |
37 |
p. 5544-5550 |
artikel |